T1	p 109 198	patients with primary Raynaud 's phenomenon in South Korea ; Korean Raynaud study ( KOARA
T2	p 205 206	)
T3	p 356 385	primary Raynaud 's phenomenon
T4	p 396 403	Korea .
T5	p 1114 1131	Korean patients .
T6	p 1174 1182	patients
T7	i 44 54	nifedipine
T8	i 78 99	Ginkgo biloba extract
T9	i 256 266	nifedipine
T10	i 287 300	nifedipine SR
T11	i 317 338	Ginkgo biloba extract
T12	i 456 475	nifedipine SR group
T13	i 495 522	Ginkgo biloba extract group
T14	i 1023 1036	nifedipine SR
T15	i 1061 1082	Ginkgo biloba extract
T16	o 21 40	efficacy and safety
T17	o 233 241	efficacy
T18	o 246 252	safety
T19	o 658 699	improvement of the RP attack rate between
T20	o 911 933	serious adverse events
T21	o 956 970	adverse events
T22	o 1034 1036	SR